SarahScottReadeMD

PubMed

• Phase I pharmacokinetic (PK) and pharmacodynamic (PD) evaluation of a small molecule inhibitor of Poly ADP-Ribose Polymerase (PARP), KU-0059436 (Ku) in patients (p) wi...
  Fong PC, Spicer J, Reade S, Reid A, Vidal L, Schellens JH, Tutt A, Harris PA, Kaye S, De Bono JS> ;J. Clin. Oncol.. 2006-06-20
• Phase I trial involving the pharmacodynamic (PD) study of circulating tumour cells, of CP-751,871 (C), a monoclonal antibody against the insulin-like growth factor 1 r...
  Attard G, Fong PC, Molife R, Reade S, Shaw H, Reid A, Spicer J, Hamlin J, Gualberto A, De Bono JS> ;J. Clin. Oncol.. 2006-06-20
• Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tu...
  de Jonge, M. J., Kaye, S., Verweij, J., Brock, C., Reade, S., Scurr, M., van Doorn, L., Verheij, C., Loos, W., Brindley, C., Mistry, P., Cooper, M., Judson, I.> ;Br J Cancer. 2004 Oct 18
• Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours.
  Harries, M., O'Donnell, A., Scurr, M., Reade, S., Cole, C., Judson, I., Greystoke, A., Twelves, C., Kaye, S.> ;Br J Cancer. 2004 Nov 1
• Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors.
  Baird, R. D., Kitzen, J., Clarke, P. A., Planting, A., Reade, S., Reid, A., Welsh, L., López Lázaro, L., de las Heras, B., Judson, I. R., Kaye, S. B., Eskens, F., Work...> ;Mol Cancer Ther. 2009 Jun 01
• Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors.
  Appleton, K., Mackay, H. J., Judson, I., Plumb, J. A., McCormick, C., Strathdee, G., Lee, C., Barrett, S., Reade, S., Jadayel, D., Tang, A., Bellenger, K., Mackay, L.,...> ;J Clin Oncol. 2007 Oct 10
• Join now to see all